πŸ‡ΊπŸ‡Έ FDA
Patent

US 7771707

Abuse-deterrent drug formulations

granted A61KA61K31/13A61K31/135

Quick answer

US patent 7771707 (Abuse-deterrent drug formulations) held by Collegium Pharmaceutical, Inc. expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Collegium Pharmaceutical, Inc.
Grant date
Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/13, A61K31/135, A61K31/20, A61K31/4458